Dr. Chalasani completed his medical education in India and subsequently completed internal medicine residency and gastroenterology and hepatology subspecialty training at Emory University in Atlanta. He currently serves as David W. Crabb Professor of Medicine and Cellular &Integrative Physiology at Indiana University School of Medicine and is the Director of its Division of Gastroenterology and Hepatology. Two broad themes to his research focus are nonalcoholic fatty liver disease and idiosyncratic drug induced liver injury and he has made several important contributions to both of these areas. He has previously served or currently serving on the editorial board of many journals including Gastroenterology (Current Associate Editor), Hepatology, Clinical Gastroenterology and Hepatology, American Journal of Medicine, Journal of Clinical Gastroenterology, and Nature Reviews Gastroenterology & Hepatology. He has been funded by the National Institutes of Health since 1998 for conducting investigations related to liver disease. He was the lead author for the multisociety practice guideline on the diagnosis and management of nonalcoholic fatty liver disease published in June 2012.